Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans
2011

Effectiveness of CMX001 Against Rabbitpox Virus in Rabbits

Sample size: 10 publication 10 minutes Evidence: high

Author Information

Author(s): Amanda D. Rice, Mathew M. Adams, Bernhard Lampert, Scott Foster, Randall Lanier, Alice Robertson, George Painter, Richard W. Moyer

Primary Institution: University of Florida

Hypothesis

Can CMX001 serve as an effective prophylactic and presymptomatic antiviral agent against rabbitpox virus in New Zealand White rabbits?

Conclusion

CMX001 is effective in preventing mortality and reducing morbidity when administered before or early in rabbitpox virus infection.

Supporting Evidence

  • CMX001 was shown to be effective in preventing lethal disease in rabbits infected with rabbitpox virus.
  • All tested doses of CMX001 provided protection against lethal rabbitpox disease.
  • Treatment with CMX001 resulted in a statistically significant reduction in disease severity.

Takeaway

CMX001 can help rabbits fight off a virus that is similar to smallpox, keeping them healthy even if they get exposed to the virus.

Methodology

New Zealand White rabbits were intradermally infected with rabbitpox virus and treated with varying doses of CMX001 to evaluate its efficacy.

Potential Biases

Potential bias in treatment administration and animal selection.

Limitations

The study was conducted in a controlled environment with a specific rabbit model, which may not fully represent human responses.

Participant Demographics

New Zealand White rabbits, 8-10 weeks old.

Statistical Information

P-Value

0.0099

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3390/v3020063

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication